Optimal level activity of matrix metalloproteinases is critical for adult visual plasticity in the healthy and stroke-affected brain
Figures

Treatment with the MMP-inhibitor GM6001 during MD period prevented OD-plasticity in adult mouse V1.
Representative examples of optically recorded activity and polar maps in V1 of both vehicle-treated mice (control, A, C) and animals treated with the MMP-inhibitor GM6001 (GM6001, B, D), before (no MD, A, B) and after monocular deprivation (7 days MD, C, D). V1-maps after visual stimulation of the contra- (contra) and ipsilateral (ipsi) eye in the binocular region of V1. Top panels (A–D) display grayscale-coded response magnitude maps (V1-activation) and their quantification on the right: histogram of (C-I)/(C+I). V1-activation is illustrated as fractional change in reflection ×10-4. Average V1-activation is illustrated as a number at the lower right corner of each magnitude map; the average OD-index (ODI) as a number in the upper right corner of the histograms. Bottom panels represent color-coded polar maps of retinotopy, and the color-coded OD-map. In both control and GM6001-treated mice without MD, V1-activity was dominated by input from the contralateral eye: activity patches after contralateral eye stimulation were darker than after ipsilateral eye stimulation, the average ODI was positive, and warm colors prevailed in the OD-map, illustrating contralateral dominance. After 7 days of MD, OD-plasticity occurred only in control (C) but not in GM6001-treated mice (D): in control mice, both eyes activated V1 rather equally strong, the OD-histogram was shifted to the left (blue arrow in C), and colder colors appeared in the OD-map. In contrast, in GM6001-treated mice, the deprived (contralateral) eye continued to dominate V1, the ODI was not reduced and warm colors still dominated the OD-map. Scale bar: 1mm.

Inhibition of MMPs during the MD-period prevented adult OD-plasticity.
(A) Optically imaged OD-indices in animals without MD (solid symbols) and after 7 days of MD (right half of symbols is black) in control (vehicle-treated, black) and in GM6001-treated mice (grey). Symbols illustrate ODI-values of individual cases; means are marked by horizontal lines. (B) V1-activation elicited by stimulation of the contralateral (C) or ipsilateral (I) eye in animals before (open circles) and after MD (closed eye marked as a black filled circle, and striped bar). The OD-shift in control mice was mediated by an increase of open eye responses in V1, while no OD-shift and no changes in V1-actiavtion were observed in GM6001-treated mice after MD. Mean ± SEM, *p<0.05, **p<0.01, ***p<0.001. ANOVA followed by multiple comparisons with Bonferroni correction was used in A; two-tailed t-test was used in B.
-
Figure 2—source data 1
Ocular dominance index and V1-activation individual values for Figure 2.
- https://doi.org/10.7554/eLife.11290.005

Inhibition of MMPs prevented experience-enabled enhancements of both the spatial frequency (A) and contrast sensitivity (B) thresholds of the optomotor reflex of the open eye in adult mice after MD.
Values of vehicle-treated (control) mice are displayed in black (triangles), values of GM6001-treated mice in grey (circles); values of animals with monocular deprivation (+MD) are marked by displaying the right half of the symbol in black. (A) Spatial frequency threshold values in cycles/degree (cyc/deg), measured in the optomotor setup plotted against days. (B) Contrast sensitivity values on day 7 at 6 different spatial frequencies. Mean ± SEM; ***p<0.001, ns p>0.05. ANOVA followed by multiple comparisons with Bonferroni correction was used; two-tailed t-test was used within the group analysis in A.
-
Figure 3—source data 1
Optomotry measured spatial frequency and contrast sensitivity thresholds individual values for Figure 3.
- https://doi.org/10.7554/eLife.11290.007

A single GM6001-treatment rescued OD-plasticity in V1 after a stroke in S1.
Representative examples of optically recorded activity and polar maps in V1 of both vehicle- (PT+vehicle, A, C) and single GM6001-treated mice (PT+1xGM6001, B, D), before (no MD, A, B) and after 7 days of MD (7days MD, C, D). V1-maps after visual stimulation of the contra- (contra) and ipsilateral (ipsi) eye in the binocular region in V1. Figure layout and data display as in Figure 1. In both vehicle- (A) and GM6001-treated PT-lesioned mice without MD (B), V1 activation was dominated by the contralateral eye: activity patches induced by contralateral eye stimulation were darker than after ipsilateral eye stimulation, the average ODI was positive, and warm colors dominated the OD-map. (C) While 7 days of MD did not induce an OD-shift in vehicle-treated PT mice, and deprived (contra) eye patches still dominated V1, a single treatment with GM6001 rescued OD-plasticity in PT mice (D): both eyes activated V1 about equally strong, the histogram of ODIs shifted to the left (blue arrow) and colder colors appeared in the OD-map. Scale bar: 1mm

Brief MMP-inhibition after a stroke in S1 rescued experience-dependent plasticity in V1.
Quantification of the imaging data, layout and data display as in Figure 2. (A) Optically imaged OD-indices in mice without MD and after 7 days of MD in vehicle-treated 1h after PT (black) mice and single GM6001-treated (PT 1xGM6001; PT+MD 1xGM6001 1 hr and PT+MD 1xGM6001 24 h, light grey) or two-times GM6001-treated (PT+MD 2xGM6001 1 h+24 h, dark grey) after PT mice. (B) V1-activation elicited by stimulation of the contralateral (C) or ipsilateral (I) eye in animals before (open circles) and after MD. V1-activation did not change after MD in vehicle-treated PT mice. In contrast, 1xGM6001 (either 1 h or 24 h) but not 2xGM6001 (1 h+24 h) treatment rescued OD-plasticity after the PT-lesion (A). There was a significant reduction in deprived eye responses in V1 in the GM6001- but not vehicle-treated mice after MD (B). Mean ± SEM, *p<0.05, **p<0.01, ***p<0.001. ANOVA followed by multiple comparisons with Bonferroni correction was used; two-tailed t-test was used within the group analysis in B.
-
Figure 5—source data 1
Ocular dominance indexes and V1-activation individual values for Figure 5.
- https://doi.org/10.7554/eLife.11290.011

Brief inhibition of MMPs after induction of a photothrombotic lesion in S1 rescued experience-enabled enhancements of both the spatial frequency (A) and contrast sensitivity (B) thresholds of the optomotor reflex in adult mice.
Values of vehicle-treated PT-mice are shown in black and values of GM6001-treated mice in grey. Layout and data presentation as in figure 3. Mean ± SEM, ***p<0.001, ns p>0.05. ANOVA followed by multiple comparisons with Bonferroni correction and two-tailed t-test was used in A within the group analysis.
-
Figure 6—source data 1
Optomotry-measured the spatial frequency and contrast sensitivity individual values for Figure 6.
- https://doi.org/10.7554/eLife.11290.013
Tables
Optomotry-measured contrast sensitivity improvements after MD
Contrast sensitivity | ||||
---|---|---|---|---|
Day 0 | ||||
Spatial frequency (cyc/deg) | Control | GM6001 | Control+MD | GM6001+MD |
0.031 | 3.6 ± 0.04 | 3.5 ± 0.02 | 3.5 ± 0.01 | 3.5 ± 0.01 |
0.064 | 12.7 ± 0.52 | 11.8 ± 0.16 | 11.6 ± 0.23 | 12.0 ± 0.15 |
0.092 | 11.7 ± 0.51 | 10.9 ± 0.18 | 10.7 ± 0.22 | 11.3 ± 0.17 |
0.103 | 10.3 ± 0.54 | 10.2 ± 0.10 | 10.0 ± 0.16 | 10.6 ± 0.12 |
0.192 | 6.9 ± 0.07 | 6.9 ± 0.12 | 7.0 ± 0.11 | 6.8 ± 0.05 |
0.272 | 3.5 ± 0.04 | 3.5 ± 0.02 | 3.5 ± 0.01 | 3.5 ± 0.01 |
Day 7 | ||||
0.031 | 3.6 ± 0.04 | 3.5 ± 0.02 | 5.1 ± 0.17 | 3.6 ± 0.02 |
0.064 | 12.7 ± 0.47 | 11.8 ± 0.18 | 26.9 ± 2.35 | 12.6 ± 0.29 |
0.092 | 11.7 ± 0.44 | 11.0 ± 0.15 | 23.3 ± 2.17 | 12.0 ± 0.22 |
0.103 | 10.5 ± 0.49 | 10.3 ± 0.10 | 21.8 ± 1.83 | 11.3 ± 0.17 |
0.192 | 7.0 ± 0.08 | 7.0 ± 0.10 | 13.5 ± 1.08 | 7.5 ± 0.21 |
0.272 | 3.5 ± 0.04 | 3.5 ± 0.01 | 4.9 ± 0.17 | 3.8 ± 0.25 |
Optomotry-measured contrast sensitivity improvements after MD
Contrast sensitivity | ||||
---|---|---|---|---|
Day 0 | ||||
Spatial frequency (cyc/deg) | PT+vehicle | PT+GM6001 | PT+MD vehicle | PT+MD GM6001 |
0.031 | 3.5 ± 0.02 | 3.5 ± 0.04 | 3.5 ± 0.02 | 3.5 ± 0.02 |
0.064 | 11.4 ± 0.35 | 11.4 ± 0.32 | 11.8 ± 0.57 | 11.8 ± 0.15 |
0.092 | 10.5 ± 0.36 | 10.5 ± 0.34 | 10.7 ± 0.39 | 11.0 ± 0.16 |
0.103 | 9.8 ± 0.26 | 9.9 ± 0.28 | 10.0 ± 0.37 | 10.0 ± 0.32 |
0.192 | 6.9 ± 0.12 | 6.7 ± 0.09 | 6.7 ± 0.13 | 6.5 ± 0.26 |
0.272 | 3.5 ± 0.03 | 3.5 ± 0.04 | 3.4 ± 0.01 | 3.5 ± 0.02 |
Day 7 | ||||
0.031 | 3.5 ± 0.02 | 3.5 ± 0.04 | 3.5 ± 0.01 | 5.0 ± 0.11 |
0.064 | 11.4 ± 0.39 | 11.5 ± 0.32 | 12.1 ± 0.42 | 25.2 ± 1.53 |
0.092 | 10.5 ± 0.36 | 10.5 ± 0.34 | 11.4 ± 0.28 | 21.9. ± 1.14 |
0.103 | 9.9 ± 0.24 | 9.9 ± 0.28 | 10.6 ± 0.26 | 19.7 ± 1.25 |
0.192 | 6.9 ± 0.11 | 6.8 ± 0.07 | 7.0 ± 0.02 | 12.8 ± 0.91 |
0.272 | 3.5 ± 0.02 | 3.5 ± 0.04 | 3.5 ± 0.02 | 4.9 ± 0.12 |